<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01827917</url>
  </required_header>
  <id_info>
    <org_study_id>BJCDPC-6</org_study_id>
    <nct_id>NCT01827917</nct_id>
  </id_info>
  <brief_title>The Protection Effect of Speeda® Rabies Vaccine for Human Use</brief_title>
  <official_title>Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Center for Disease Control and Prevention</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to achieve the post-marketing protective effect research of
      Speeda® rabies vaccine for human use from Chengda Bio.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When found the injury who is bitten by the animal to three-level, the investigators would
      enroll the participant after explaining the protection and making him signed the informed
      consent. The patient would inject rabies vaccine as follow the national regulation, meanwhile
      the investigators would get the blood samples to detect whether the man-killer carries the
      rabies virus.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Observation of the subject after injured by the animals carrying the virus</measure>
    <time_frame>2 years</time_frame>
    <description>Whether or when would the patients develop symptoms after injured by the animals carrying the virus</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Rabies Vaccine Allergy</condition>
  <arm_group>
    <arm_group_label>rabies vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>When injured by the animal who carries the rabies virus, the patient after standard treatment would survive or die</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>rabies vaccine</intervention_name>
    <description>Injection on day 0、7、21</description>
    <arm_group_label>rabies vaccine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parent/legal acceptable representatives of children or the adult participants are
             willing and able to understand the protocol requirements and provide informed consent
             signed

          -  Participant is considered to be in good health including the body and mental status on
             the basis of reported medical history and limited physical examination and live in
             local ≥ 12 months before injured

          -  The man-killer could found and detect whether it carries the virus

        Exclusion Criteria:

          -  Known bleeding disorder or suspected impairment of immunologic function, or receipt of
             immunosuppressive therapy or immunoglobulin since birth

          -  Apply passive immunity preparation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nianmin Shi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chaoyang District Centers for Disease Control and Prevention</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hunan Centers for Disease Control and Prevention</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2013</study_first_posted>
  <last_update_submitted>January 19, 2016</last_update_submitted>
  <last_update_submitted_qc>January 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rabies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

